Compare Citius Pharmaceuticals Inc (CTXR) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Home Depot Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.49 (market cap $13.79M), while Home Depot Inc trades at $295.98 (market cap $285.11B). The key difference: Home Depot Inc is far larger — about 20675.1× Citius Pharmaceuticals Inc's market cap, and Home Depot Inc pays a 3.26% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Citius Pharmaceuticals Inc for 16 Days and Home Depot Inc for 139 Days on average.
| CTXR | HD | |
|---|---|---|
Market Cap | $13.79M | $285.11B |
Volume | 156,684 | 5,334,053 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $391.90 |
52-Week Low | $0.48 | $281.15 |
Typical Hold Time | 16 Days | 139 Days |
Enterprise Value | $3.96M | $345.59B |
Dividend Yield | — | 3.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.5082, up 5.72% today, but remains in a bearish technical trend with negative profitability metrics. The company reported $7.1M revenue for the first nine months of 2026 from LYMPHIR sales, though net income margin remains deeply negative at -651.27%. Analyst consensus is strongly bullish with 5 buy ratings and a $5.00 price target, representing significant upside potential from current levels.
While CTXR shows promising commercial progress with its oncology drug launch, the stock faces substantial execution risks due to persistent losses and cash burn. The bullish analyst sentiment contrasts with weak fundamentals, creating a high-risk, high-reward scenario for investors betting on successful commercialization of LYMPHIR in the $400M+ CTCL market.
Home Depot (HD) trades at $295.47, up 3.06% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $159.51B in 2025, with net income of $14.81B and a net margin of 8.41%. Recent quarterly earnings have consistently beaten expectations, including Q2 2026 EPS of $4.92 versus $4.73 expected. Cash flow from operations remains strong at $19.81B in 2025, though net cash flow was negative due to significant investing outlays. The stock is near its 52-week low, with key support at $282.
The outlook for HD is mixed; strong Pro segment demand and housing tailwinds support long-term growth, but near-term headwinds include weak big-ticket demand and margin pressure. Analyst consensus is bullish with a $379.93 price target, yet rising mortgage rates and competitive pressures pose risks. Investment appeal hinges on execution in a challenging housing market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
